Tag: Crizotinib

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Crizotinib

Pfizer Gets EC OK for Lorviqua as First-Line Treatment for ALK-Positive Advanced Lung ...

Added to Collection on: 2022-01-28 18:08:35

Tags for this article:

Chemical compounds
Organic compounds
Aromatic compounds
Breakthrough therapy
Piperidines
Lung cancer
Tyrosine kinase receptors
Anaplastic lymphoma kinase
Ceritinib
Crizotinib
ALK inhibitor
Alectinib

Click the tags to see associated articles and topics

View Article Details
Pfizer (PFE) Lorviqua Gets EU Nod for First-Line Lung Cancer - Entrepreneur

Added to Collection on: 2022-01-31 18:16:09

Tags for this article:

Chemical compounds
Organic compounds
Chemistry
Breakthrough therapy
Piperidines
Lung cancer
Tyrosine kinase receptors
Ceritinib
ALK inhibitor
Anaplastic lymphoma kinase
Crizotinib
Alectinib

Click the tags to see associated articles and topics

View Article Details
Pfizer's Lorbrena shows PFS improvement in Phase III lung cancer trial

Added to Collection on: 2022-04-11 14:12:56

Tags for this article:

Chemical compounds
Organic compounds
Aromatic compounds
Lung cancer
Tyrosine kinase receptors
Piperidines
ALK inhibitor
Orphan drugs
Anaplastic lymphoma kinase
Crizotinib
Lorlatinib
Non-small-cell lung carcinoma
XALKORI
pfizer global

Click the tags to see associated articles and topics

View Article Details
BMS bets $4.1B on lung cancer drug that could best products from Pfizer, Roche

Added to Collection on: 2022-06-03 19:24:01

Tags for this article:

Chemical compounds
Organic compounds
Aromatic compounds
Tyrosine kinase receptors
Breakthrough therapy
ROS1
Lung cancer
Orphan drugs
Entrectinib
Anaplastic lymphoma kinase
Non-small-cell lung carcinoma
Crizotinib

Click the tags to see associated articles and topics

View Article Details
Non Small Cell Lung Cancer Therapeutics Market Size Share Trends Growth Statistics and ...

Added to Collection on: 2022-09-05 08:51:41

Tags for this article:

Health
Lung cancer
Companies
Cancer
Non-small-cell lung carcinoma
Small-cell carcinoma
Pharmaceutical industry in China
Targeted therapy
Boehringer Ingelheim
Genentech
Crizotinib
Merck & Co.

Click the tags to see associated articles and topics

View Article Details
Updates: MET targeted therapy for EXON 14 mutations in lung cancer - EurekAlert!

Added to Collection on: 2023-09-12 13:58:34

Tags for this article:

Breakthrough therapy
Lung cancer
Orphan drugs
Antineoplastic drugs
Chloroarenes
Crizotinib
Non-small-cell lung cancer
Capmatinib
Tyrosine kinase
Protein kinase inhibitor
Tepotinib
ROS1

Click the tags to see associated articles and topics

View Article Details
A novel IGR-ALK fusion in a patient with lung adenocarcinoma | OTT - Dove Medical Press

Added to Collection on: 2024-03-26 16:24:41

Tags for this article:

Lung cancer
CYP3A4 inhibitors
Pyrazoles
Piperidines
Orphan drugs
ALK inhibitor
Anaplastic lymphoma kinase
Crizotinib
Ceritinib
Adenocarcinoma of the lung
Non-small-cell lung cancer
Alectinib

Click the tags to see associated articles and topics

View Article Details
Lorlatinib vs Crizotinib in Advanced ALK-Positive NSCLC: 5-Year Outcomes From Phase III ...

Added to Collection on: 2024-08-08 15:58:08

Tags for this article:

Fluoroarenes
Pyrazoles
Lung cancer
Tyrosine kinase receptors
CYP3A4 inhibitors
Lorlatinib
Crizotinib
Brain metastasis
Anaplastic lymphoma kinase
Non-small-cell lung cancer
Survival rate
Protein kinase inhibitor
Benjamin J. Solomon

Click the tags to see associated articles and topics

View Article Details
FDA Alert: Pulmonology Drug Approvals, Recalls, and Device Updates

Added to Collection on: 2025-01-24 15:50:32

Tags for this article:

Orphan drugs
CYP3A4 inhibitors
Cystic fibrosis
Antineoplastic drugs
Durvalumab
Ivacaftor
Tezacaftor
Respiratory syncytial virus
ALK inhibitor
Non-small-cell lung cancer
Crizotinib
Anaplastic lymphoma kinase

Click the tags to see associated articles and topics

View Article Details
Strategic and Safe Lorlatinib Use Is Key to Optimal ALK+ NSCLC Management - OncLive

Added to Collection on: 2025-02-21 21:19:48

Tags for this article:

Pyrazoles
Orphan drugs
Lung cancer
Tyrosine kinase receptors
Antineoplastic drugs
Lorlatinib
ALK inhibitor
Crizotinib
Anaplastic lymphoma kinase
Non-small-cell lung cancer
ALK positive lung cancer
ROS1
Alectinib

Click the tags to see associated articles and topics

View Article Details